UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome Journal article
THERANOSTICS, 2019,Volume: 9,Issue: 13,Page: 3952-3965
Authors:  Dapeng Hao;  Jingjing Li;  Jianlin Wang;  Yuan Meng;  Zhiqiang Zhao;  Chao Zhang;  Kai Miao;  Chuxia Deng;  Benjamin K. Tsang;  Li Wang;  Li-jun Di
Favorite  |  View/Download:9/0  |  Submit date:2020/05/21
Ovarian Cancer  Estrogen Signaling  Deficiency Of Homologous-recombination  Chemotherapy  Hormone Replacement  
A Jak2-selective inhibitor potently reverses the immune suppression by modulating the tumor microenvironment for cancer immunotherapy Journal article
BIOCHEMICAL PHARMACOLOGY, 2017,Volume: 145,Page: 132-146
Authors:  He, Wei;  Zhu, Yi;  Mu, Ruoyu;  Xu, Jinzhi;  Zhang, Xiaoyi;  Wang, Chunming;  Li, Qiu;  Huang, Zhen;  Zhang, Junfeng;  Pan, Yi;  Han, Jianlin;  Dong, Lei
Favorite  |  View/Download:16/0  |  Submit date:2018/10/30
Tumor Associated Macrophages  Regulatory t Cells  Jak2-stat3 Pathway  Tumor Immunotherapy